Discovery of a Novel Series of Imidazopyrazine Derivatives as Potent SHP2 Allosteric Inhibitors
Esther Torrente, Valentina Fodale, Alina Ciammaichella et al. · ACS Medicinal Chemistry Letters · 2023
Protein tyrosine phosphatase SHP2 is an oncogenic protein that can regulate different cytokine receptor and receptor tyrosine kinase signaling pathways. We report here the identification of a novel series of SHP2 allosteric inhibitors having an imidazopyrazine 6,5-fused heterocyclic system as the central scaffold that displays good potency in enzymatic and cellular assays. SAR studies led to the identification of compound 8, a highly potent SHP2 allosteric inhibitor. X-ray studies showed novel stabilizing interactions with respect to known SHP2 inhibitors. Subsequent optimization allowed us to identify analogue 10, which possesses excellent potency and a promising PK profile in rodents.
Cited by 22 works. doi:10.1021/acsmedchemlett.2c00454 Open-access PDF
Authors
- Esther Torrente
- Valentina Fodale
- Federica Ferrigno
- Jesus M. Ontoria
- Simona Ponzi
- Ilaria Rossetti
- Alessio Sferrazza
- Jérôme Amaudrut
- Antonino Missineo
- Simone Esposito
- Simone Palombo
- Martina Nibbio
- Mauro Cerretani
- Monica Bisbocci
- Antonella Cellucci
- Annalise Di Marco
- Cristina Alli
- Vincenzo Pucci
- Carlo Toniatti
References
- Crystal Structure of the Tyrosine Phosphatase SHP-2
- The ‘Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling
- Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases
- Activating Mutations of the Noonan Syndrome-Associated SHP2/PTPN11 Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia
- The tyrosine phosphatase Shp2 (PTPN11) in cancer
- Molecular Mechanism for a Role of SHP2 in Epidermal Growth Factor Receptor Signaling
- Germ-line and somatic PTPN11 mutations in human disease
- The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors
- An Shp2/SFK/Ras/Erk Signaling Pathway Controls Trophoblast Stem Cell Survival
- Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor